NASHUA, N.H., Feb. 14, 2022 (GLOBE NEWSWIRE) —
iCAD, Inc.
(NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the fourth quarter and year ended December 31, 2021, after the market close, and host a conference call at 4:30 PM Eastern Time on Monday, February 28.
Monday, February 28th at 4:30 PM ET
| Domestic: | 877-407-0784 |
| International: | 201-689-8560 |
| Conference ID: | 13726987 |
| Webcast: |
https://themediaframe.com/mediaframe/webcast.html?webcastid=ELUrpENc |
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit
www.icadmed.com
.
Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
[email protected]
Investor Inquiries:
iCAD Investor Relations
[email protected]
